drugset / Trial / NCT01901575

Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia

NCT01901575

Phase 4 Completed 16 enrolled NYU Langone Health
NaSingle-groupOpen-labelTreatment

Summary

Determine effects of remifentanil conscious sedation in patients undergoing Electrophysiological (EP) studies for the ablation of idiopathic ventricular tachycardia and/or persistent frequent premature ventricular contractions (PVCs) of non-ischemic origin

Timeline

Start
2011-07
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule Intravenous